Brainsway (NASDAQ: BWAY) director details stock options and 6,250 RSUs
Rhea-AI Filing Summary
Brainsway Ltd. director Lushi Avner reported initial equity holdings consisting of stock options and restricted stock units tied to the company’s ordinary shares. The filing shows stock options to purchase 12,500 ordinary shares, granted on March 5, 2024, with the remaining options vesting in equal quarterly installments until March 5, 2028 and expiring on March 5, 2034. The exercise price for these options is NIS 11.17 per share. In addition, Avner holds 6,250 unvested RSUs, each representing a contingent right to receive one ordinary share, vesting quarterly until March 5, 2028. The ordinary shares may be represented by American Depositary Shares, with each ADS currently corresponding to one ordinary share.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (4)
- F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2. This figure represents unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
- F3. Stock options were granted on March 5, 2024, with the remaining options to purchase 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
- F4. The exercise price is NIS 11.17 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.